Skip to main content
. 2023 Apr 19;76(Suppl 1):S97–S105. doi: 10.1093/cid/ciad044

Table 2.

Clinical Presentation of Attributable Cryptosporidium Moderate-to-Severe Diarrhea Cases Compared With All Other Watery Diarrhea

Cryptosporidium-Attributed MSD
(n = 465)
All
Watery MSDa
(n = 3680)
P
Demographic features
Age, median (IQR), months 12 (9, 20) 15 (9, 25) <0.001*
ȃSex, n (%)
Female 204 (43.9%) 1724 (46.8%) 0.245
ȃȃMale 261 (56.1%) 1956 (53.2%)
Findings at enrollment
ȃNo. of median (IQR)diarrhea days prior to SHC visit 3 (2–4) 3 (2–3) <0.001*
ȃMental status, n (%)
ȃȃNormal 355 (76.3%) 2608 (70.9%) 0.048*
ȃȃRestless/irritable 96 (20.6%) 936 (25.4%)
ȃȃLethargic/unconscious 14 (3%) 136 (3.7%)
ȃFever (temperature >38°C or parental perception), n (%) 284 (61.1%) 2068 (56.2%) 0.048*
ȃVomiting, n (%) 267 (57.4%) 1722 (46.8%) <0.001*
ȃSunken eyes, more than normal, n (%) 449 (96.6%) 3580 (97.3%) 0.458
ȃOral mucosa, n (%)
ȃȃNormal 92 (19.8%) 734 (19.9%) 0.996
ȃȃSomewhat dry 351 (75.5%) 2774 (75.4%)
ȃȃVery dry 22 (4.7%) 172 (4.7%)
ȃSkin pinch, n (%)
ȃȃNormal 319 (68.6%) 2542 (69.1%) .551
ȃȃSlow return 141 (30.3%) 1114 (30.3%)
ȃȃVery slow return 5 (1.1%) 24 (0.7%)
ȃWHO-defined dehydration, n (%)
ȃȃNone 33 (7.1%) 175 (4.8%) 0.013*
ȃȃSome 380 (81.7%) 2955 (80.3%)
ȃȃSevere 52 (11.2%) 550 (14.9%) ȃ
ȃModified Vesikari score, n (%) ȃ ȃ ȃ
ȃȃMild 109 (23.4%) 1205 (32.8%) <.001*
ȃȃModerate 179 (38.5%) 1479 (40.2%) ȃ
ȃȃSevere 177 (38.1%) 992 (27.0%) ȃ
ȃȃMedian (IQR) 9 (7, 11) 8 (6,11) <.001*
ȃStunted, n (%) ȃ ȃ ȃ
ȃȃHAZ ≥ –2 357 (76.8%) 2867 (77.9%) 0.621
ȃȃHAZ < –2 108 (23.2%) 813 (22.1%) ȃ
ȃUndernourished (wasted/very thin), n (%) 109 (23.4%) 541 (14.7%) <0.001*
ȃSevere acute malnutrition, n (%) ȃ ȃ
ȃMUAC ≥115 mm 429 (92.3%) 3581 (97.3%) <.001*
ȃMUAC <115 mm 36 (7.7%) 99 (2.7%) ȃ
ȃAbnormal hair (sparse, loose, straight), n (%) 26 (5.6%) 111 (3%) .005*
ȃ“Flaky paint” appearance of the skin, n (%) 5 (1.1%) 20 (0.5%) .191
ȃRequired rehydration, n (%) ȃ ȃ ȃ
ȃȃNo 8 (1.7%) 3 (0.1%) <0.001*
ȃȃYes, oral alone 403 (86.7%) 3396 (92.3%) ȃ
ȃȃYes, oral and IV 54 (11.6%) 281 (7.6%) ȃ
ȃAdmitted to the hospital, n (%) 33 (7.1%) 182 (5.0%) 0.064
Findings at follow-up n = 445 (95.7%) n = 3538 (96.1%) ȃ
ȃTotal no. of days with diarrhea 6 (4–9) 5 (3–8) <.001*
ȃDiarrhea duration stratum, n (%) ȃ ȃ ȃ
ȃȃAcute (1–6 days) 253 (56.9%) 2380 (67.3%) <.001*
ȃȃProlonged (7–13 days) 137 (30.8%) 835 (23.6%) ȃ
ȃȃPersistent (≥14 days) 55 (12.4%) 323 (9.1%) ȃ
ȃChange in HAZ −0.29 (−0.52, 0.00) −0.17 (−0.42, 0.03) <0.001*
ȃUndernourished (wasted/very thin), n (%) 6 (1.3%) 234 (6.6%) 0.337
ȃMUAC <115 mm, n (%) 4 (0.9%) 26 (0.7%) 0.320
ȃStunted, n (%) ȃ ȃ ȃ
ȃȃHAZ ≥ –2 332 (71.4%) 2749 (74.7%) 0.128
ȃȃHAZ < –2 133 (28.6%) 931 (25.3%) ȃ
ȃDied, n (%) 6 (1.3%) 26 (0.7%) 0.162

Statistically significant. Abbreviations: HAZ, height-for-age z score; IQR, interquartile range; IV, intravenous, MSD, moderate-to-severe diarrhea; MUAC, mid-upper arm circumference; PCR, polymerase chain reaction; SHC, sentinel health center; WHO, World Health Organization.

Episodes with positive PCR for Cryptosporidium that did not meet criteria for attributed were excluded from this analysis.